Table 5.
No. | Form | Conc. | Chemical antioxidant tests | Biological text of in vitro | Exp. parameters | Biological activity | Pathway | References |
---|---|---|---|---|---|---|---|---|
1 | GLP | 0.5-3.0 mg/mL | RS FR |
= | Scavenging of free radicals and reducing power | Antioxidant | NM | [89] |
2 | G. lucidum and Egyptian Chlorella vulgaris | CVE (63.5 μg/mL) was mixed with GLE (4.1 μg/mL) | RS FR AP Other tests |
Lipopolysaccharide-stimulated white blood cells | Nitric oxide, tumor necrosis factor- (TNF-) α | Antioxidant and anti-inflammatory | Downregulate NF-κB | [39] |
3 | Polysaccharides in G. lucidum | 2 mg/mL | RS FR AP Other tests |
NM | Radical scavenging reducing power | Antioxidant | NM | [90] |
4 | G. lucidum extract | 50 mg | RS FR AP Other tests |
NM | Reducing power | Antimicrobial and antioxidant | NM | [40] |
5 | Ganoderma lucidum G2 | 0.32 mg | RS FR AP Other tests |
DNA protection | Radical scavenging reducing power | Antimicrobial and antioxidant | NM | [41] |
6 | Protein extracts | 2–13 μg protein/mL | AP Other tests |
DNA protection | Radical scavenging reducing power | Antioxidant, antibacterial | NM | [42] |
7 | Polysaccharides extraction | = | FR AP Other tests |
MCF-7 breast cancer cell line and HeLa cells | Radical scavenging | Antioxidant Anticancer |
NM | [43] |
8 | G. lucidum and G. resinaceum | 0.1–1 & 0.64 ± 0.04 0–2.25 mg/mL |
FR AP Other tests |
In vitro cell line | Radical-scavenging chelating lipoxygenase assay | Antiproliferative & antioxidant | NM | [44] |
9 | Diff, organic solvent o G. lucidum | 1-200 μg/mL | FR AP Other tests |
NM | Radical scavenging, chelating lipid peroxidation | Antioxidant Anticholinesterase |
NM | [45] |
10 | Both aqueous and methanolic extracts | 0.2–30 mg/mL of extraction | FR AP Other tests |
NM | Radical scavenging, chelating lipid peroxidation | Antioxidant | NM | [46] |
11 | Low-molecular-weight β-1,3-glucan | 0–200 μg/mL | AP Other tests |
Mouse monocyte-macrophage cell line, RAW 264.7 | H2O2-induced apoptosis | Antioxidant | Attenuating intracellular reactive oxygen species (ROS) and inhibiting sphingomyelinase (SMase) activity | [51] |
12 | Polysaccharides | 0.16-10 mg/mL | FR AP Other tests |
NM | Radical scavenging, chelating reducing power | Antioxidant | NM | [47] |
13 | G. lucidumwater-soluble and water-insoluble | 80-1100 μg/ml | FR AP Other tests |
Human uroepithelial cell (HUC-PC) cells | Radical scavenging, chelating reducing power | Antioxidant | Oxidative DNA damage. Lingzhi-induced apoptosis in bladder chemoprevention | [48] |
14 | Ganoderma lucidum polysaccharides | 0.1-0.6 mg/ml | RS | CCl-induced injury hepatocytes DNA protection | MDA, SOD, CYP3A, caspase-3, andcaspase-8 | Suppressing inflammatory responses | Reduction of NF-κB activation inhibition of caspase-3, caspase-6, and caspase-9, indicating and suppression extrinsic-induced apoptosis | [52] |
15 | Ganoderic acid A | 10-80 lM/mL | NM | Pancreatic cells | Radical scavenging Antiproliferative |
Antioxidant Anticancer |
β-Catenin in Wnt signaling pathway | [54] |
16 | Aqueous extract of G. lucidum | 5-20 μL | NM | DNA protection | Radical scavenging | Antioxidant DNA repair |
Enhancing reactivity of apurinic/apyrimidinic endonucleases (APE1) a major enzyme of base excision repair (BER) | [91] |
17 | Methanolic extract of G. lucidum | 65 & 130 μg/mL | NM | Human gastric tumor cells | Increased the formation of autophagosomes | Induces autophagy | Increasing of the cellular levels of LC3-II and decreasing p62 (autophagy-related protein) | [92] |
18 | G. lucidum (GLPS) and G. sinense (GSPS) | 19–300 μg/mL | NM | RAW 264.7 mouse macrophage cells | Nitric oxide secretion of cytokines | Immunomodulatory | Promoting macrophage phagocytosis, increasing their release of nitric oxide and cytokines interleukin- (IL-) 1a, IL-6, IL-10, and tumor necrosis factor-α | [56] |
19 | Proteopolysaccharide from G. lucidum | 2 - 10 μg/mL | NM | RAW264.7, a mouse macrophage cell line | Nitrite production Expression levels of cytokines |
Activation the immune system by modulating cytokine production. | NM | [57] |
NM = not mention; RS = radical scavenging; FR = ferric reducing; AP = antilipid peroxidation.